Article
Targeting the Malaria Parasite cGMP-Dependent Protein Kinase to Develop New Drugs
17 Dec 2020
Abstract excerpt
is responsible for the majority of deaths due to malaria each year. The selection of drug resistance has been a recurring theme over the decades with each new drug that is developed. It is therefore crucial that future generations of drugs are explored to tackle this major public health problem. Cyclic GMP (cGMP) signaling is one of the biochemical pathways that is being explored as a potential target for new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
